Miglustat (hydrochloride), CAS 210110-90-0

Product Description: Miglustat (N-Butyldeoxynojirimycin) hydrochloride is an orally active and reversible ceramide glucosyltransferase inhibitor. Miglustat hydrochloride can be used for the research of type I gaucher disease[1][2].

Applications: Neuroscience-Neuromodulation

Formula: C10H22ClNO4

Citations: Cell. 2019 Dec 12;179(7):1483-1498.e22./Cell Rep. 2022 Jul 5;40(1):111049./Nat Commun. 2024 Aug 14;15(1):6970./Preprints. 2023 Dec 20.

References: [1]Maria Cristina Dechecchi, et al. Anti-inflammatory effect of miglustat in bronchial epithelial cells. J Cyst Fibros. 2008 Nov;7(6):555-65. /[2]G D'Arcangelo, et al. Miglustat Reverts the Impairment of Synaptic Plasticity in a Mouse Model of NPC Disease. Neural Plast. 2016:2016:3830424.

CAS Number: 210110-90-0

Molecular Weight: 255.74

Compound Purity: 98.0

Research Area: Inflammation/Immunology; Neurological Disease

Solubility: DMSO : 65 mg/mL (ultrasonic)/H2O : ≥ 34 mg/mL

Target: Glucosylceramide Synthase (GCS)

• SKU: MEXHY-17020A-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-17020A-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK